SCHEMBL1231192

SCHEMBL1231192

NS(=O)(=O)c1c[nH]c2c(Nc3ccccc3)nccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR174 Q9BXC1 1/20 0.43
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 2/20 0.40
AR P10275 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
HTR6 P50406 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TTBK1 Q5TCY1 1/20 0.40
TTBK2 Q6IQ55 1/20 0.40
ENPP3 O14638 2/20 0.39
ROCK1 Q13464 1/20 0.39
TNNI3K Q59H18 1/20 0.39
BRD4 O60885 1/20 0.38
DHODH Q02127 1/20 0.38
CCNT1 O60563 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29745666 0.74 NPC1 (0.69) GPR174NPC1HPGDHTTLMNA
SCHEMBL15067758 0.74 NPC1 (0.69) GPR174NPC1HPGDHTTLMNA
SCHEMBL28315134 0.66 MET (0.65) CA1CA2CA9CCNT1CDK2
SCHEMBL30286312 0.66 MET (0.65) CA1CA2CA9CCNT1CDK2
SCHEMBL31193469 0.66 EGFR (0.61) NPC1HPGDNPSR1CDK1CCNB1
SCHEMBL28315195 0.66 CA1 (0.56) HTTLMNACA12CA1CA2
SCHEMBL31088267 0.66 CA1 (0.56) HTTLMNACA12CA1CA2
SCHEMBL2037022 0.63 DHODH (0.57) NPC1HTTARTTBK1TTBK2
SCHEMBL29778738 0.63 MPO (0.50) CA12CA1CA2CA9CDK2
SCHEMBL28040105 0.63 EGFR (0.65) CA12CA1CA2CA9ENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011019634-A2 ARYL SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS TAIPEI MEDICAL UNIVERSITY (TW) 2011-02-17 WO disclosed